Subjects with preexisting cardiovascular symptoms who were receiving subutramine, an appetite suppressant, were found to be at increased risk of cardiovascular events while taking the drug. The study included 10162 overweight or obese subjects with preexisting cardiovascular disease and/or type 22 diabetes. The subjects were randomly assigned to subutramine (5083 subjects) or a placebo (5079 subjects) in a double‑blind fashion. The primary outcome measured was the occurrence of any of the following events: nonfatal myocardial infarction or stroke, resuscitation after cardiac arrest, or cardiovascular death. The primary outcome was observed in 572 subjects in the subutramine group and 506 subjects in the placebo group. Do the data give good reason to think that there is a difference between the proportions of treatment and placebo subjects who experienced the primary outcome? (Note that sibutramine has not been available in the United States since the end of 2010 due to its manufacturer's concerns over increased risk of heart attack or stroke, although at the present time, it can still be purchased in other countries.) State hypotheses and then find the test statistic. Give your answer to two decimal places. ?=     Use either software or the bottom row of Table C for the ?-value.. Give your answer to four decimal places. ?-value:

Holt Mcdougal Larson Pre-algebra: Student Edition 2012
1st Edition
ISBN:9780547587776
Author:HOLT MCDOUGAL
Publisher:HOLT MCDOUGAL
Chapter11: Data Analysis And Probability
Section: Chapter Questions
Problem 8CR
icon
Related questions
Question

Subjects with preexisting cardiovascular symptoms who were receiving subutramine, an appetite suppressant, were found to be at increased risk of cardiovascular events while taking the drug. The study included 10162 overweight or obese subjects with preexisting cardiovascular disease and/or type 22 diabetes. The subjects were randomly assigned to subutramine (5083 subjects) or a placebo (5079 subjects) in a double‑blind fashion. The primary outcome measured was the occurrence of any of the following events: nonfatal myocardial infarction or stroke, resuscitation after cardiac arrest, or cardiovascular death. The primary outcome was observed in 572 subjects in the subutramine group and 506 subjects in the placebo group.

Do the data give good reason to think that there is a difference between the proportions of treatment and placebo subjects who experienced the primary outcome?

(Note that sibutramine has not been available in the United States since the end of 2010 due to its manufacturer's concerns over increased risk of heart attack or stroke, although at the present time, it can still be purchased in other countries.)

State hypotheses and then find the test statistic. Give your answer to two decimal places.

?=
 
 

Use either software or the bottom row of Table C for the ?-value.. Give your answer to four decimal places.

?-value:
 
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 4 steps with 3 images

Blurred answer
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Holt Mcdougal Larson Pre-algebra: Student Edition…
Holt Mcdougal Larson Pre-algebra: Student Edition…
Algebra
ISBN:
9780547587776
Author:
HOLT MCDOUGAL
Publisher:
HOLT MCDOUGAL
College Algebra
College Algebra
Algebra
ISBN:
9781938168383
Author:
Jay Abramson
Publisher:
OpenStax